Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
3.890
+0.300 (8.36%)
At close: Nov 6, 2026, 4:00 PM EST
3.750
-0.140 (-3.60%)
After-hours: Nov 6, 2026, 7:30 PM EST
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $170.74 million as of November 6, 2026. It is the 21,414th most valuable company in the world and the 3,663rd biggest in the United States. Its market cap has decreased by 82.32% in one year.
Market Cap
170.74M
Enterprise Value
158.84M
1-Year Change
-82.32%
Global Rank
Country Rank
#3,663 United States
Category
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has decreased from $219.46M to $170.74M, a decrease of -22.20%. That is a compound annual growth rate of -13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 170.74M | -87.06% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 493.30M |
| Embecta | 350.72M |
| Sanara MedTech | 289.88M |
| Jin Medical International | 263.53M |
| OraSure Technologies | 237.25M |
| Utah Medical Products | 229.33M |
| Pro-Dex | 202.10M |
| KORU Medical Systems | 142.67M |